摘要
目的:探讨黄芪四君子汤联合成分输血对肝癌患者术后免疫功能的影响。方法:将110例接受肝动脉化疗栓塞术(Transcatheter arterial chemoembolization,TACE)治疗的肝癌患者随机分为两组。对照组55例,采用复方甘草酸苷注射液联合成分输血治疗;治疗组55例,采用黄芪四君子汤联合成分输血治疗。比较治疗前后两组外周血T淋巴细胞亚群指标(CD3^+、CD4^+、CD8^+、CD4^+/CD8^+)、自然杀伤细胞(NK)、临床症状的变化情况及不良反应发生情况,并对两组临床疗效进行评价。结果:两组治疗后均CD3^+、CD4^+、NK细胞均上升,中医证候积分均下降,且治疗组上述观察指标均优于对照组,差异均有统计学意义(P<0.05);治疗组总有效率为90.91%(50/55),高于对照组的75.55%(41/55),差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:黄芪四君子汤联合成分输血可有效提高肝癌患者术后免疫功能,缓解临床症状,提高临床疗效。
Objective: To investigate the effect of Huangqi Sijunzi decoction combined with blood component transfusion on postoperative immune function in patients with liver cancer. Methods: A total of 110 patients with liver cancer received transcatheter arterial chemoembolization (TACE) were randomly divided into two groups. Control group (n=55) took compound glycyrrhizin injectioncombined with blood component transfusion; treatment group (n=55) took Huangqi Sijunzi decoction combined with blood component transfusion. The peripheral blood T lymphocyte subsets indexes (T cell subset, CD3+, CD4+, CD8+, CD4+/CDS+), natural killer (NK) cell, changes of clinical symptoms and adverse reactions of two groups before and after treatment were compared. The clinical efficacy was evaluated in two groups. Results: Compared with pre-treatment, the CD3+, CD4+, NK cell increased in two groups, while TCM symptom scores decreased, and the treatment group showed better above-mentioned indexes than control group (P〈0.05); The total effective rate of treatment group was 90.91% (50/55), which was higher than 75.55% (41/55) of control group (P〈0.05); There was no statistical difference in the incidence of ad- verse reactions between the two groups (P〉0.05). Conclusion: Huangqi Sijunzi decoction combined with blood component transfusion for patients with liver cancer can effectively increase postoperative immune function, re- lieve clinical symptoms and increase clinical efficacy.
出处
《中医药导报》
2017年第21期50-53,共4页
Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金
陕西省科技攻关资助项目(2015SF058)
关键词
肝癌
肝动脉化疗栓塞术
黄芪四君子汤
成分输血
免疫功能
不良反应
liver cancer
Transcatheter arterial chemoembolization
Huangqi Sijunzi decoction
blood compo- nent transfusion
immune function
adverse reactions